The Zacks Analyst Blog Highlights: LinkedIn, Facebook, Microsoft, ON Semiconductor and Humana


For Immediate Release
Chicago, IL – February 05, 2014 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the LinkedIn Corp (LNKD-Free Report), Facebook Inc. (FB-Free Report), Microsoft (MSFT-Free Report), ON Semiconductor Corp. (ONNN-Free Report) and Humana Inc. (HUM-Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Tuesday’s Analyst Blog:

Will LinkedIn (LNKD) Disappoint This Earnings Season?
LinkedIn Corp (LNKD-Free Report) is set to report fourth-quarter fiscal 2013 results on Feb 6. Last quarter, the company posted a negative earnings surprise of 100.0%. Let’s see how things are shaping up for this announcement.
Growth Factors this Past Quarter
LinkedIn delivered mixed third-quarter results. Although, the company’s top line surpassed the Zacks Consensus Estimate, the bottom line missed the consensus mark. Year-over-year revenues benefited the most from growth in its Talent Solution and Premium Subscription businesses.
Additionally, LinkedIn is gaining traction on the mobile and tablet platforms, which are expected to generate additional revenues. The company is expected to continue its investments in the near term, which might impact its profitability.
Moreover, we believe that LinkedIn’s rapid growth and new product rollouts could lead to poorer service levels. Also, there is a possibility that companies like Facebook Inc. (FB-Free Report), Microsoft (MSFT-Free Report) and Twitter will develop competing solutions and enter this adjacent market.
The emergence of companies likes ValueClick Inc., which have been introducing new services at regular intervals, could also bring about a rapid change in the scenario.
Earnings Whispers?    
Our proven model does not conclusively show that LinkedIn will beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank of #1, 2 or 3 for this to happen. That is not the case here as you will see below.

Zacks ESP:  Both the Most Accurate estimate and the Zacks Consensus Estimate stand at 9 cents. Hence, the difference is 0.00%.
Zacks Rank #4 (Sell): We caution against stocks with Zacks Ranks #4 and #5 (Sell rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.
Other Stocks to Consider
Here is another company which investors may want to consider as our model shows it has the right combination of elements to post an earnings beat this quarter:  
ON Semiconductor Corp. (ONNN-Free Report), Earnings ESP of +14.29% and a Zacks Rank #2 (Buy).
Will Humana (HUM) Miss Earnings?

Humana Inc. (HUM-Free Report) is set to report fourth-quarter 2013 results on Feb 5, 2014. Last quarter, it posted a 6.94% surprise. Let’s see how things are shaping up for this announcement.

Factors this Past Quarter

Although the launch of the “Humana Helps” campaign, the Accountable Care agreement with St. Luke’s University Health Network, and investments in the trend vendor initiatives like Humana Chronic Cares Program and in-home care for Humana members are expected to help the company enhance revenues, a number of negatives are likely to mar the overall results in the upcoming quarter.  Humana has been witnessing rising expenses on account of higher operating cost and depreciation and amortization costs. Moreover, an expected increase in medical costs in the Employer segment in 2014 is believed to mar company financials going forward.

Additionally, since Humana is heavily reliant on Medicare Advantage revenue the health care reform that has reduced the selling season for the Medicare Advantage plans are spelling bad news for the company. Also, ban on annual and lifetime coverage caps, annual fees on health insurance companies and excise tax on high premium insurance policies, will likely increase expenses pressurizing margins. Pricing pressure from competitors, particularly from BlueCross BlueShield and increased capital expenditures to settle lawsuits are likely to dampen the results further.

Earnings Whispers?

Our proven model shows that Humana will lag earnings this quarter. That is because the stock has a negative Earnings ESP (Expected Surprise Prediction) and a Zacks Rank of #4.

Negative Zacks ESP:  That is because the Most Accurate estimate stands at 89 cents whereas the Zacks Consensus Estimate stands at 93 cents, making the difference –4.30%.

Zacks Rank #4 (Sell): Humana’s Zacks Rank #4 decreases the predictive power of ESP. We caution against stocks with Zacks Rank #4 and 5 (Sell-rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum as is the case here.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on LNKD - FREE
Get the full Report on FB - FREE
Get the full Report on MSFT - FREE
Get the full Report on ONNN - FREE
Get the full Report on HUM - FREE
Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Read the analyst report on LNKD

Read the analyst report on FB

Read the analyst report on MSFT

Read the analyst report on ONNN

Read the analyst report on HUM

Zacks Investment Research

View Comments (0)